Risk factors | Positive TST result | Positive QFT-GIT | Positive T-SPOT.TB | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
n = 41 | n = 70 | n = 56 | ||||||||||
Univariate | Multivariate | Univariate | Multivariate | Univariate | Multivariate | |||||||
 | OR | 95% CI | OR | 95% CI | OR | 95% CI | OR | 95% CI | OR | p | OR | 95% CI |
Male | 1.75 | 0.81-3.77 | Â | Â | 2.92 | 1.49-5.75 | 2.92 | 1.49-5.75 | 1.93 | 0.97-3.84 | 1.82 | 0.90-3.67 |
Age (per year) | 1.01 | 0.97-1.05 | Â | Â | 1.01 | 0.97-1.04 | Â | Â | 1.04 | 1.004-1.08 | 1.04 | 1.003-1.08 |
Imprisonment | 2.31 | 1.08-4.92 | 2.09 | 0.88-4.97 | 2.22 | 1.14-4.31 | Â | Â | 1.78 | 0.88-3.61 | Â | Â |
Unemployment | 0.80 | 0.38-1.69 | Â | Â | 1.22 | 0.63-2.34 | Â | Â | 1.15 | 0.57-2.33 | Â | Â |
On ART | 0.19 | 0.06-0.62 | 0.15 | 0.04-0.52 | 0.80 | 0.42-1.53 | Â | Â | 0.66 | 0.32-1.39 | Â | Â |
VL <75 | 0.34 | 0.08-1.48 | Â | Â | 0.63 | 0.24-1.63 | Â | Â | 1.10 | 0.44-2.73 | Â | Â |
CD4 <100 | - | - | Â | Â | - | - | Â | Â | - | - | Â | Â |
100 < CD4 <200 | 1.85 | 0.61-5.65 | 0.92 | 0.35-2.42 | 1.34 | 0.53-3.36 | ||||||
CD4 >200 | 1.44 | 0.59-3.55 | 1.32 | 0.66-2.65 | 0.71 | 0.34-1.47 | ||||||
Hepatitis C Ab + | 2.38 | 1.19-4.77 | 2.18 | 1.01-4.71 | 1.72 | 0.98-3.00 | Â | Â | 1.78 | 0.97-3.26 | Â | Â |
Hepatitis B sAG + | 1.39 | 0.28-6.96 | Â | Â | 2.00 | 0.52-7.68 | Â | Â | 4.36 | 1.13-16.85 | 5.13 | 1.24-21.17 |
Household Member treated for TB | 1.48 | 0.39-5.62 | Â | Â | 0.43 | 0.09-1.97 | Â | Â | 1.48 | 0.44-5.00 | Â | Â |
BCG | 2.55 | 0.32-20.18 | Â | Â | 1.41 | 0.38-5.29 | Â | Â | 1.78 | 0.38-8.28 | Â | Â |
Tobacco | 1.32 | 0.65-2.71 | Â | Â | 2.02 | 1.09-3.75 | Â | Â | 1.16 | 0.62-2.18 | Â | Â |
ETOH (AUDIT > = 8) | 1.42 | 0.57-3.54 |  |  | 0.94 | 0.41-2.16 |  |  | 1.87 | 0.84-4.17 |  |  |
Drug Use (DART > =3) | 2.02 | 1.02-4.01 |  |  | 2.33 | 1.31-4.16 |  |  | 1.42 | 0.76-2.64 |  |  |